Europe Opioid Drugs Market 2019-2028

MARKET OUTLOOK

The publisher's report has determined the opioid drugs market in Europe to proliferate at a compound annual growth rate of 2.53% during the forecast period 2019-2028. Russia, Spain, Germany, Italy, France, the UK, and Rest of Europe together shape the market in this region.
A 2018 study published in the British Journal of General Practice states that, in the United Kingdom, there has been an increase in long-term opioid prescription. In Russia, the pain experienced in people having an advanced stage of cancer is one of the frequently encountered types of chronic pain. Thus, strong opioids, such as morphine and fentanyl, are prescribed to them, in accordance with the three-step protocol by the World Health Organization.

Further, in 2017, the NIH reported that, the prevalence of general chronic pain among adult patients in the Netherlands was around 18%. And, the rate of prevalence of cancer pain among the patients, in the preceding year, was almost 55%. Opioids play a vital role in alleviating the pain of patients suffering from such conditions. All the above-mentioned factors indicate an increase in the demand for opioid drugs in Europe. This, in turn, is helping the growth of the opioid drugs market in the region over the coming period. However, it must be noted that, in 2016, 1,333 people lost their lives to opioid drug overdose in Germany. This is a matter of grave concern, needing increased efforts by the national governments in the region, to spread awareness about substance abuse.

COMPETITIVE OUTLOOK

The major organizations that have established their presence in this market are Biodelivery Sciences International Inc, Collegium Pharmaceutical Inc, Cipher Pharmaceuticals Inc, Acura Pharmaceuticals, Teva Pharmaceutical Industries Ltd, Allergan (Acquired By Abbvie), Johnson Johnson, Sanofi-Aventis SA, and Sun Pharmaceutical Industries Ltd.

1. Europe Opioid Drugs Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Technological Advancements to Fight Against Opioid Drug Crisis
2.2.2. Different Sources of Procuring Opioids
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Growth in Medical Cases & Rising Prevalence of Cancer
2.6.2. Increase in the Use of Abuse-Deterrent Formulations to Restrict the Rise of Opioid Dependence
2.6.3. Demand for Palliative Therapy
2.7. Market Restraints
2.7.1. Government Rules and Regulations
2.7.2. Increased Number of Lawsuits Against the Manufacturers of Opiod Drugs
2.7.3. Usage of Opioids for Non-Medical Purposes
2.8. Market Opportunities
2.8.1. Rising Commercial Success and Market Share of Opioid Drugs
2.8.2. Growth of Investments in Research of Pharmaceutical Uses of Opioids
2.9. Market Challenges
2.9.1. Opioid Epidemic Spreading
2.9.2. Rising Death Rate Due to Opioid Overdose
2.10. Covid-19 Impact on the Opioid Drugs Market

3. Europe Opioid Drug Market Outlook - by Product

3.1. Buprenorphine
3.2. Fentanyl
3.3. Hydrocodone
3.4. Morphine
3.5. Oxycodone
3.6. Tramadol
3.7. Other Products

4. Europe Opioid Drugs Market Outlook - by Application

4.1. Pain Relief
4.1.1. Cancer Pain
4.1.2. Postoperative Pain Management
4.1.3. Lower Back Pain
4.1.4. Orthopedic
4.1.5. Neuropathic
4.1.6. Fibromyalgia
4.2. Anesthesia
4.3. Cough Suppression
4.4. Diarrhea Suppression
4.5. De-Addiction

5. Europe Opioid Drugs Market – Regional Outlook

5.1. United Kingdom
5.2. Germany
5.3. France
5.4. Spain
5.5. Italy
5.6. Russia
5.7. Rest of Europe

6. Competitive Landscape

6.1. Acura Pharmaceuticals
6.2. Biodelivery Sciences International Inc
6.3. Cipher Pharmaceuticals Inc
6.4. Allergan (Acquired by Abbvie)
6.5. Collegium Pharmaceutical Inc
6.6. Daiichi Sankyo
6.7. Hikma Pharmaceuticals plc
6.8. Indivior Inc
6.9. Janssen Pharmaceuticals Inc
6.10. Johnson Johnson
6.11. Lannett Co Inc
6.12. Lupin Ltd
6.13. Mylan Nv
6.14. Pfizer Inc
6.15. Purdue Pharma Lp
6.16. Sanofi-Aventis Sa
6.17. Sun Pharmaceutical Industries Ltd
6.18. Teva Pharmaceutical Industries Ltd

7. Methodology & Scope

7.1. Research Scope & Deliverables
7.2. Sources of Data
7.3. Research Methodology

List of Tables:

Table 1: Europe Opioid Drugs Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Europe Opioid Drugs Market, by Product, 2019-2028 (In $ Million)
Table 4: Europe Opioid Drugs Market, by Application, 2019-2028 (In $ Million)
Table 5: Europe Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Table 6: Europe Opioid Drugs Market, by Country, 2019-2028 (In $ Million)

List of Figures:

Figure 1: Porter's Five Force Analysis
Figure 2: Market Attractiveness Index
Figure 3: Europe Opioid Drugs Market, by Buprenorphine, 2019-2028 (In $ Million)
Figure 4: Europe Opioid Drugs Market, by Fentanyl, 2019-2028 (In $ Million)
Figure 5: Europe Opioid Drugs Market, by Hydrocodone, 2019-2028 (In $ Million)
Figure 6: Europe Opioid Drugs Market, by Morphine, 2019-2028 (In $ Million)
Figure 7: Europe Opioid Drugs Market, by Oxycodone, 2019-2028 (In $ Million)
Figure 8: Europe Opioid Drugs Market, by Tramadol, 2019-2028 (In $ Million)
Figure 9: Europe Opioid Drugs Market, by Other Products, 2019-2028 (In $ Million)
Figure 10: Europe Opioid Drugs Market, by Pain Relief, 2019-2028 (In $ Million)
Figure 11: Europe Opioid Drugs Market, by Cancer Pain, 2019-2028 (In $ Million)
Figure 12: Europe Opioid Drugs Market, by Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 13: Europe Opioid Drugs Market, by Lower Back Pain, 2019-2028 (In $ Million)
Figure 14: Europe Opioid Drugs Market, by Orthopedic, 2019-2028 (In $ Million)
Figure 15: Europe Opioid Drugs Market, by Neuropathic, 2019-2028 (In $ Million)
Figure 16: Europe Opioid Drugs Market, by Fibromyalgia, 2019-2028 (In $ Million)
Figure 17: Europe Opioid Drugs Market, by Anesthesia, 2019-2028 (In $ Million)
Figure 18: Europe Opioid Drugs Market, by Cough Suppression, 2019-2028 (In $ Million)
Figure 19: Europe Opioid Drugs Market, by Diarrhea Suppression, 2019-2028 (In $ Million)
Figure 20: Europe Opioid Drugs Market, by De-Addiction, 2019-2028 (In $ Million)
Figure 21: Europe Opioid Drugs Market; Regional Outlook 2019 & 2028 (In %)
Figure 22: United Kingdom Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 23: Germany Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 24: France Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 25: Spain Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 26: Italy Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 27: Russia Opioid Drugs Market, 2019-2028 (In $ Million)
Figure 28: Rest of Europe Opioid Drugs Market, 2019-2028 (In $ Million)